{"entity":{"type":"insider","cik":"0001553593","url":"/insider/0001553593","json_url":"/insider/0001553593.json","name":"Dunne Michael W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2013-02-14","last":"2025-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Dunne Michael W.","source":"filing","n_filings":12,"first_seen":"2013-02-14","last_seen":"2025-11-20"}],"transactions":[{"id":4880126,"accession":"0001193125-25-288848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-288848","line_url":"/filing/0001193125-25-288848#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.3652,"price_display":"0.37","price_state":"stated","total_value":2191.2,"total_display":"2,191.20","total_whole":"2,191","shares_owned_after":241001.0,"shares_owned_after_display":"241,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4715119,"accession":"0000950170-25-106908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-106908","line_url":"/filing/0000950170-25-106908#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.7236,"price_display":"0.72","price_state":"stated","total_value":10854.0,"total_display":"10,854.00","total_whole":"10,854","shares_owned_after":235001.0,"shares_owned_after_display":"235,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-08-12","scope":"insider"},{"id":7924152,"accession":"0001209191-23-059750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059750","line_url":"/filing/0001209191-23-059750#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":113754.0,"shares_owned_after_display":"113,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-27","scope":"insider"},{"id":8471590,"accession":"0001209191-23-059133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059133","line_url":"/filing/0001209191-23-059133#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.8442,"price_display":"1.84","price_state":"stated","total_value":18442.0,"total_display":"18,442.00","total_whole":"18,442","shares_owned_after":88754.0,"shares_owned_after_display":"88,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-19","scope":"insider"},{"id":8335711,"accession":"0001209191-23-056685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056685","line_url":"/filing/0001209191-23-056685#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0345,"price_display":"2.03","price_state":"stated","total_value":40690.0,"total_display":"40,690.00","total_whole":"40,690","shares_owned_after":78754.0,"shares_owned_after_display":"78,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-27","scope":"insider"},{"id":6700040,"accession":"0001209191-22-049352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-049352","line_url":"/filing/0001209191-22-049352#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":22200.0,"total_display":"22,200.00","total_whole":"22,200","shares_owned_after":35576.0,"shares_owned_after_display":"35,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-09","scope":"insider"},{"id":5275424,"accession":"0000899243-21-003519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-003519","line_url":"/filing/0000899243-21-003519#line-2","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33143.0,"shares_display":"33,143","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":57337.39,"total_display":"57,337.39","total_whole":"57,337","shares_owned_after":256355.0,"shares_owned_after_display":"256,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider"},{"id":2419254,"accession":"0000899243-20-029501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-029501","line_url":"/filing/0000899243-20-029501#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61540.0,"shares_display":"61,540","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":209498.0,"shares_owned_after_display":"209,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-27","filed_date":"2020-10-28","scope":"insider"},{"id":6295967,"accession":"0001209191-18-049884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-049884","line_url":"/filing/0001209191-18-049884#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":147958.0,"shares_owned_after_display":"147,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6523626,"accession":"0001209191-18-048708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-048708","line_url":"/filing/0001209191-18-048708#line-2","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":147458.0,"shares_owned_after_display":"147,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-27","filed_date":"2018-08-28","scope":"insider"},{"id":6523625,"accession":"0001209191-18-048708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-048708","line_url":"/filing/0001209191-18-048708#line-1","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":146958.0,"shares_owned_after_display":"146,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-24","filed_date":"2018-08-28","scope":"insider"},{"id":6824340,"accession":"0001209191-18-034172","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034172","line_url":"/filing/0001209191-18-034172#line-4","is_derivative":false,"issuer_cik":"0001553593","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553593","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":26000.0,"total_display":"26,000.00","total_whole":"26,000","shares_owned_after":146458.0,"shares_owned_after_display":"146,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":5446313,"accession":"0001181431-13-009830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-009830","line_url":"/filing/0001181431-13-009830#line-1","is_derivative":false,"issuer_cik":"0001544116","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001544116","owner_cik":"0001553593","owner_name":"Dunne Michael W.","owner_display_name":"Dunne Michael W.","owner_url":"/insider/0001553593","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":13220.0,"shares_owned_after_display":"13,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2013-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Director, Officer (Chief Scientific Officer)","n_filings":11,"first_seen":"2018-05-30","last_seen":"2025-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2013-02-14","last_seen":"2013-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553593","retrieved_at":"2026-08-23T18:06:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}